Roche Holding Ltd. (NASDAQ:RHHBY) has been assigned a consensus broker rating score of 1.67 (Buy) from the three analysts that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and two have issued a strong buy rating on the company.
Brokers have set a 1 year consensus target price of $34.65 for the company, according to Zacks. Zacks has also given Roche Holding an industry rank of 171 out of 265 based on the ratings given to related companies.
Several analysts have issued reports on RHHBY shares. Jefferies Group LLC reiterated a “buy” rating on shares of Roche Holding in a research note on Sunday, February 19th. Sanford C. Bernstein reiterated an “overweight” rating on shares of Roche Holding in a research note on Wednesday, December 7th.
Shares of Roche Holding (NASDAQ:RHHBY) traded down 0.71% during mid-day trading on Monday, hitting $32.19. 576,815 shares of the company traded hands. The stock has a market capitalization of $219.40 billion and a PE ratio of 23.34. Roche Holding has a 1-year low of $25.25 and a 1-year high of $33.77. The firm’s 50 day moving average price is $30.04 and its 200-day moving average price is $29.69.
A number of hedge funds have recently bought and sold shares of RHHBY. S&T Bank PA purchased a new stake in Roche Holding during the fourth quarter valued at about $141,000. Delaney Dennis R boosted its stake in Roche Holding by 18.3% in the third quarter. Delaney Dennis R now owns 7,305 shares of the company’s stock valued at $227,000 after buying an additional 1,130 shares in the last quarter. Cadence Bank NA boosted its stake in Roche Holding by 11.5% in the fourth quarter. Cadence Bank NA now owns 8,718 shares of the company’s stock valued at $249,000 after buying an additional 901 shares in the last quarter. Moloney Securities Asset Management LLC purchased a new stake in Roche Holding during the fourth quarter valued at about $258,000. Finally, Opus Capital Group LLC boosted its stake in Roche Holding by 0.7% in the third quarter. Opus Capital Group LLC now owns 8,999 shares of the company’s stock valued at $280,000 after buying an additional 64 shares in the last quarter.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Get a free copy of the Zacks research report on Roche Holding (RHHBY)